Coherus Biosciences reported $448.28M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 521.55M 10.97M
Aerie Pharmaceuticals AERI:US USD 302.81M 8.6M
Akebia Therapeutics AKBA:US USD 237.51M 66.65M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Amarin AMRN:US USD 686.52M 32.6M
Amgen AMGN:US USD 24.06B 4.74B
Baxter International BAX:US USD 7.81B 72M
Biogen BIIB:US USD 9.77B 24.9M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Coherus Biosciences CHRS:US USD 448.28M 1.49M
Eli Lilly And LLY:US USD 17.64B 524.7M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Fujifilm 4901:JP JPY 1.86T 30.59B
Gilead Sciences GILD:US USD 13.9B 723M
Horizon Pharma HZNP:US USD 3.41B 208.92M
Ironwood Pharmaceuticals IRWD:US USD 698.99M 81.17M
Myriad Genetics MYGN:US USD 352.3M 14.8M
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Revance Therapeutics RVNC:US USD 415.59M 154.65M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Teva Pharmaceutical TEVA:IT USD 11.45B 711M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
Xencor XNCR:US USD 668M 82.06M
Zoetis ZTS:US USD 6.55B 100M